Anteris Technologies Global
AVR
6.82
-0.23
-3.26%
Anteris Technologies Global
US · AVR
#3553 by market cap
Listed 2024
6.82
-0.23
-3.26%
Live - 5344 symbols - heartbeat 297s ago
· 2026-10-08 08:03
Pre-market
6.85
+0.44%
After-hours
6.88
+0.88%
- Market cap
- 664.67M
- P/E (TTM)i
- -3.50
- P/Bi
- 2.64
- EPSi
- -2.55
- Div yieldi
- 0.00%
- 52W posi
- 45%
Reader sentiment
Are you bullish or bearish on AVR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -19.13, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -29.23% YoY
Margins
- Gross margin
- 70.26%
- Operating margin
- -4,920.86%
- Net margin
- -4,921.28%
Key ratios & quality
- Enterprise valuei
- 652.69M
- Altman Z-Scorei
- -19.13
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | 2.70M | 1.91M |
| Gross profit | 8.76M | 5.81M | 5.01M | 4.46M | 1.77M | 1.71M | 1.27M | 1.34M |
| Selling & admin expenses | 16.57M | 15.69M | 9.50M | 10.51M | 16.08M | 24.95M | 28.19M | 26.12M |
| Research & development | 2.38M | 2.32M | 3.56M | 5.81M | 8.99M | 15.57M | 51.45M | 69.12M |
| Operating profit | -16.39M | -17.55M | -12.93M | -16.68M | -32.24M | -48.12M | -77.33M | -94.14M |
| Pretax profit | -17.40M | -4.33M | -11.74M | -16.61M | -30.16M | -47.06M | -75.97M | -94.23M |
| Tax | 0 | 0 | 0 | 0 | 0 | -127.67K | 0 | 0 |
| Net profit | -17.40M | -4.33M | -11.74M | -16.61M | -30.16M | -46.94M | -75.97M | -94.23M |
| Basic EPS | -6 | -1 | -2 | -2 | -2 | -3 | -4 | -3 |
| Diluted EPS | -5.59 | -0.69 | -1.99 | -2.24 | -2.26 | -2.94 | -3.68 | -2.55 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 556.00K | 618.00K | 429.00K | 310.00K | 494.00K | 1.01M |
| Gross profit | 349.00K | 470.00K | 306.00K | 219.00K | 380.00K | 776.00K |
| Selling & admin expenses | 5.67M | 5.01M | 5.76M | 9.67M | 6.93M | 8.40M |
| Research & development | 16.46M | 16.34M | 16.81M | 19.51M | 17.46M | 23.37M |
| Operating profit | -21.78M | -20.88M | -22.27M | -29.21M | -24.01M | -31.00M |
| Pretax profit | -21.93M | -21.06M | -22.21M | -29.02M | -22.41M | -28.78M |
| Tax | 0 | 0 | 0 | 0 | 492.00K | 0 |
| Net profit | -21.93M | -21.06M | -22.21M | -29.02M | -22.90M | -28.78M |
| Basic EPS | -1 | -1 | -1 | -1 | 0 | 0 |
| Diluted EPS | -0.61 | -0.58 | -0.62 | -0.75 | -0.28 | -0.30 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 16.14M | 14.41M | 6.22M | 18.73M | 12.29M | 24.45M | 74.65M | 15.68M |
| Cash & ST investments | 8.48M | 11.27M | 3.35M | 15.44M | 9.39M | 21.01M | 70.46M | 12.58M |
| Inventory | 4.71M | 1.27M | 533.18K | 549.30K | 357.09K | 440.61K | 513.00K | 152.00K |
| Total assets | 22.44M | 18.20M | 9.73M | 21.37M | 15.97M | 31.14M | 80.70M | 23.00M |
| Total current liabilities | 6.76M | 5.11M | 6.03M | 9.38M | 5.13M | 9.42M | 16.56M | 21.37M |
| Short-term debt | -- | 1.02M | 2.27M | 3.85M | 515.13K | 666.29K | 750.00K | 582.00K |
| Long-term debt | -- | -- | -- | -- | -- | 118.74K | -- | 22.00K |
| Total liabilities | 7,312,330.50 | 7,328,953.87 | 7,876,250.74 | 10,970,661.41 | 6,980,984.94 | 11,608,796.96 | 18,017,000.00 | 23,250,000.00 |
| Total equity | 15.13M | 10.88M | 1.85M | 10.40M | 8.99M | 19.53M | 62.68M | -253.00K |
| Retained earnings | -80.07M | -83.66M | -103.62M | -114.30M | -137.43M | -184.24M | -276.39M | -370.53M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 52.98M | 32.21M | 11.22M | 15.68M | 286.67M | 260.65M |
| Cash & ST investments | 48.96M | 28.44M | 9.12M | 12.58M | 282.70M | 256.87M |
| Inventory | 364.00K | 449.00K | 436.00K | 152.00K | 122.00K | 8.00K |
| Total assets | 58.79M | 39.88M | 19.07M | 23.00M | 294.72M | 272.51M |
| Total current liabilities | 14.43M | 13.34M | 13.43M | 21.37M | 13.69M | 18.36M |
| Short-term debt | 1.46M | 1.07M | 720.00K | 582.00K | 1.31M | 1.03M |
| Long-term debt | 30.00K | 30.00K | 26.00K | 22.00K | 18.00K | 47.00K |
| Total liabilities | 15,679,000.00 | 15,846,000.00 | 15,715,000.00 | 23,250,000.00 | 16,311,000.00 | 20,837,000.00 |
| Total equity | 43.11M | 24.03M | 3.36M | -253.00K | 278.41M | 251.67M |
| Retained earnings | -298.25M | -319.09M | -341.33M | -370.53M | -393.56M | -422.65M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- | -61.24M | -77.80M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | 1.51M | 1.66M |
| Free cash flow | -16.07M | -16.06M | -11.27M | -14.20M | -28.17M | -37.47M | -63.52M | -79.76M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 24.94M | 96 | 821.25K | 26.71M | 23.74M | 53.78M | 119.64M | 25.82M |
| Ending cash balance | 8.48M | 6.28M | 3.35M | 15.44M | 9.39M | 21.01M | 70.46M | 12.58M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -21.49M | -19.54M | -18.25M | -18.53M | -28.68M | -20.80M |
| Depreciation & amortization | 403.00K | 418.00K | 417.00K | 423.00K | 429.00K | 469.00K |
| Free cash flow | -21.74M | -20.07M | -19.02M | -18.92M | -28.86M | -21.45M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 618.00K | 1.00K | 0 | 25.20M | 308.27M | 0 |
| Ending cash balance | 48.96M | 28.44M | 9.12M | 12.58M | 283.21M | 260.89M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -131.93 | -31.64 | -184.56 | -271.07 | -311.09 | -322.17 | -185.52 | -300.45 |
| ROA %i | -76.55 | -20.05 | -84.09 | -106.79 | -161.55 | -194.76 | -136.43 | -181.58 |
| ROIC %i | -117.78 | -25.48 | -131.00 | -161.28 | -241.94 | -295.34 | -179.67 | -285.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | -186.06 | -224.11 | -254.88 | -278.06 |
| EBIT margin %i | -86.17 | -33.08 | -159.10 | -274.59 | -942.53 | -1,668.84 | -2,808.73 | -4,921.69 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.39 | 2.82 | 1.03 | 2.00 | 2.40 | 2.60 | 4.51 | 0.73 |
| Quick ratioi | 1.69 | 2.57 | 0.76 | 1.85 | 1.94 | 2.32 | 4.44 | 0.60 |
| Debt / assetsi | -- | 10.06 | 29.90 | 19.43 | 5.99 | 5.49 | 1.73 | 9.92 |
| LT debt / equityi | -- | 7.50 | 34.45 | 2.94 | 4.91 | 5.35 | 1.03 | -- |
| Interest coveragei | -8.36 | -10.60 | -25.38 | -14.13 | -40.14 | -144.96 | -1,615.32 | -1,289.75 |
| Revenue CAGR (3Y) %i | 27.13 | 3.58 | -22.24 | -32.09 | -36.08 | -26.66 | -21.78 | -15.07 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -189.11 | -595.21 | -2,280.10 | -300.45 | -59.25 | -75.10 |
| ROA %i | -139.14 | -291.37 | -442.06 | -181.58 | -53.92 | -66.31 |
| ROIC %i | -180.55 | -510.48 | -1,392.74 | -285.72 | -58.18 | -73.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -3,276.73 | -3,385.28 | -3,942.59 | -4,921.69 | -5,112.16 | -4,559.86 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.67 | 2.41 | 0.84 | 0.73 | 20.93 | 14.20 |
| Quick ratioi | 3.52 | 2.18 | 0.70 | 0.60 | 20.66 | 14.02 |
| Debt / assetsi | 3.44 | 7.04 | 12.33 | 9.92 | 1.27 | 1.22 |
| LT debt / equityi | 1.31 | 7.13 | 44.10 | -- | 0.87 | 0.91 |
| Interest coveragei | -1,458.73 | -1,252.55 | -1,187.77 | -1,289.75 | -1,278.73 | -558.64 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Development and commercialization of the DurAVR ® THV System which includes the ADAPT ®100.00%
Quote time 2026-10-08 08:03:19 · For reference only, not investment advice and not tailored to your situation.